Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - REVENUE
Revenue AKBA - Akebia Therapeutics, Inc.
195 M
LAST VALUE
-4.54%
2 YEAR CAGR
-1.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR